Three assays for detection of rubella antibodies, Rubella G (fluorescence immunoassay [FIA]), Rubacell (passive hemagglutination), and Rubaquick (passive hemagglutination with rotation), were compared with hemagglutination inhibition. A total of 100 serum specimens were selected, 68 of which had an FIA value of sz25. On initial testing, among the four tests, there was agreement for 88 specimens for assignment of rubella immune status. On repeat testing, all the results agreed by the hemagglutination inhibition, passive hemagglutination, and passive hemagglutination-rotation methods, and only one discrepant specimen remained by FIA.
Three assays for detection of rubella antibodies, Rubella G (fluorescence immunoassay [FIA] ), Rubacell (passive hemagglutination), and Rubaquick (passive hemagglutination with rotation), were compared with hemagglutination inhibition. A total of 100 serum specimens were selected, 68 of which had an FIA value of sz25. On initial testing, among the four tests, there was agreement for 88 specimens for assignment of rubella immune status. On repeat testing, all the results agreed by the hemagglutination inhibition, passive hemagglutination, and passive hemagglutination-rotation methods, and only one discrepant specimen remained by FIA.
Historically, hemagglutination inhibition (HAI) has been the reference method for detection of rubella antibodies (1, 4, 6, 11) . However, many investigators have reported this procedure to be labor intensive and difficult to perform (4, 5, 8, 16) . Furthermore, the necessary pretreatment of serum may remove rubella antibodies, resulting in false-negative results, and the incomplete removal of beta lipoproteins can cause false-positive results (5, 7) . Because of the shortcomings of the HAI test, this method is being replaced in most clinical laboratories with less cumbersome methods that avoid the aforenamed problems (2, 3, 9-11, 13, 14) . For most serological assays, specimens that are distinctively positive or negative usually result in a high degree of agreement between the different methods compared. The specimens that offer a challenge to the laboratory are those with borderline results (4, 7, 12, 13, 15, 16 Table 1 . Of the samples, 79% (79/100) were immune by HAI and 21% (21/100) were nonimmune. On initial testing, the PHA had the highest sensitivity (100%) and the FIA had the lowest sensitivity (92%). On the other hand, the FIA had the highest specificity (95%), whereas the PHA and PHAR both had a specificity of 71%. The FIA had the highest positive predictive value on initial testing (99%) and the lowest negative predictive value (77%). By comparison on initial testing, the PHA and PHAR both had a positive predictive value of 93% and had negative predictive values of 100 and 83%, respectively.
The 12 serum samples that gave discrepant results were retested by all four methods (Tables 1 and 2) . Upon repeat testing, 11 of the 12 discordant samples came to an agreement as immune for a final HAI result of 85% (85/100) immune and 15% (15/100) nonimmune. The three methods in relation to the HAI results had 100% specificity, the PHA and the PHAR had a sensitivity of 100%, and the FIA had a sensitivity of 99%. The positive predictive value was 100% for all three methods, whereas the negative predictive value was 94% for the FIA and 100% for the PHA and the PHAR.
The performance characteristics of all four assays from initial and repeat testing were compared with the consensus result of all the tests combined ( Table 2 ). The specificity of the four tests was 100%, both on initial and repeat testing. The initial sensitivities of FIA and HAI were the lowest, at 87 and 93%, respectively. On initial testing, the PHA compared the best of all methods in all parameters with the consensus result. On repeat testing, all the initial falsenegatives by FIA (12%) and HAI (6%) resolved, except for one discrepant serum sample by FIA, for final sensitivities of 99% for FIA and 100% for HAI. The positive predictive value was 100% for all assays on initial and repeat testing, when compared with the consensus result. On the other hand, the negative predictive values were significantly low for FIA (58%) and HAI (71%) on initial testing but improved to 94 and 100%, respectively, on repeat testing.
Reagent and equipment cost, turnaround time, and technical time of the assays are summarized in Table 3 . HAI compared the least favorably in this analysis, mainly because of the extensive technical time involved. PHAR had the shortest turnaround time (1.5 h), but the required technical time was 1 h. FIA had moderate technical and turnaround times and the least expensive reagent costs, which made it the least expensive kit, but it had a substantially high equipment cost. PHA was the second least expensive in total cost and required no additional equipment, making it the most cost-effective assay of the four compared here.
The most important parameters to evaluate in a rubella screening test are specificity and positive predictive values. These two parameters indicate the amount of false-positive results and, thus, the proportion of individuals who will not be receiving the necessary immunizations (6). For our study, we selected mainly specimens which were low-level positive or negative, since they often present difficulties in accurately assigning rubella immune status results (4, 5, 7, 8, 12) . For example, Wittenburg et al. (15) tested 55 serum samples, of which 35 were negative or had low HAI titers, with six commercial rubella virus antibody kits and found that the sensitivity of these kits ranged from 67 to 100% and that the specificity ranged from 62 to 100% when compared with the HAI method. Similar problems have been reported by Steece et al. (12) when using an enzyme immunoassay for determining immune status in samples with borderline antibody titers.
HAI, although still considered the reference method for determining rubella immune status, is a difficult and timeconsuming test to perform. In a previous report from our laboratory, for 9 of 95 serum samples with an HAI antibody 
